Eyecyte-RPE

· Eyestem Research Pvt. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eyecyte-RPE, covering 2024-09-24 to 2024-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. [Phase 1, Phase 2]

See pricing